| 查看: 728 | 回复: 7 | ||||
[交流]
STM：靶向作用脂肪激素或可开发出治疗2型糖尿病的新型疗法
|
||||
|
12月23日，来自哈佛大学的一个研究团队通过研究描述了一种临床前的方法或可帮助治疗2型糖尿病、脂肪肝及其它代谢性疾病，文章中研究者开发了一种抗体，其可以改善通过靶向作用脂肪组织中名为aP2（FABP4）的激素来帮助改善机体的葡萄糖调节，并且降低肥胖小鼠集体的脂肪肝症状。 Development of a therapeutic monoclonal antibody that targets secreted fatty acid–binding protein aP2 to treat type 2 diabetes http://stm.sciencemag.org/content/7/319/319ra205 Kill the messenger A variety of metabolic messengers—many from adipose tissue itself—controls the energy state of organs and organisms. Recently, researchers showed that the fatty acid binding protein aP2, once thought to live and work only in the cytoplasm, is also secreted by adipose tissue and spurs metabolic changes in other organs. Now, Burak and colleagues test whether secreted aP2 can serve as a therapeutic target for type 2 diabetes. In mice, the secreted form of aP2 regulates glucose production in liver, systemic glucose homeostasis, and insulin resistance. Serum levels of aP2 were shown to be elevated in obese mice and humans and to correlate with metabolic complications. The authors identified a monoclonal antibody to aP2 that lowered fasting blood glucose, increased insulin sensitivity, and lowered both fat mass and fatty liver (steatosis) in obese mouse models, relative to a control antibody, but not in aP2-deficient mice. The antidiabetic effects of the therapeutic antibody were linked to the regulation of hepatic glucose output and peripheral glucose utilization. Together, these findings suggest that an aP2-targeted antibody that kills the messenger is a viable approach for diabetes treatment. Abstract The lipid chaperone aP2/FABP4 has been implicated in the pathology of many immunometabolic diseases, including diabetes in humans, but aP2 has not yet been targeted for therapeutic applications. aP2 is not only an intracellular protein but also an active adipokine that contributes to hyperglycemia by promoting hepatic gluconeogenesis and interfering with peripheral insulin action. Serum aP2 levels are markedly elevated in mouse and human obesity and strongly correlate with metabolic complications. These observations raise the possibility of a new strategy to treat metabolic disease by targeting serum aP2 with a monoclonal antibody (mAb) to aP2. We evaluated mAbs to aP2 and identified one, CA33, that lowered fasting blood glucose, improved systemic glucose metabolism, increased systemic insulin sensitivity, and reduced fat mass and liver steatosis in obese mouse models. We examined the structure of the aP2-CA33 complex and resolved the target epitope by crystallographic studies in comparison to another mAb that lacked efficacy in vivo. In hyperinsulinemic-euglycemic clamp studies, we found that the antidiabetic effect of CA33 was predominantly linked to the regulation of hepatic glucose output and peripheral glucose utilization. The antibody had no effect in aP2-deficient mice, demonstrating its target specificity. We conclude that an aP2 mAb–mediated therapeutic constitutes a feasible approach for the treatment of diabetes. |
回复此楼» 收录本帖的淘帖专辑推荐
 新药资讯 |
» 猜你喜欢
一志愿苏州大学 生物技术与工程（086001） 初试323分，求调剂
已经有0人回复
-
三年实验室工作经历，一志愿华中农业大学微生物，总分288求调剂
已经有5人回复
-
药理学论文润色/翻译怎么收费?
已经有83人回复
-
070700求调剂
已经有1人回复
-
求调剂总分327
已经有1人回复
-
【招聘】清北（济南）生物科技招聘AI制药研发计算人才
已经有18人回复
-
100701药学专业招调剂，5个名额，药物化学专业，主要是天然药物化学方向加药理
已经有4人回复
-
【2026 硕士调剂】 全国重点实验室 药学 化学 生物学 生物与医药
已经有0人回复
-
药学 化学 生物学 生物与医药 河南师范大学抗病毒性传染病创新药物全国重点实验室
已经有0人回复
-
江西师大化学工程学院调剂今晚0点开放！ 缺额100个，速冲！
已经有7人回复
» 抢金币啦！回帖就可以得到:
-
2026年博士研究生·哈工程先进核能材料与辐照效应研究团队
+1/287
-
想做生物创新药的有福啦—南昌大学生物医学创新研究院/药学院陈川课题组招收博士生
+1/193
-
★★爆★★0860生物与医药调剂考生看过来，河北大学化学与材料科学学院
+2/158
-
河南师范大学材料学院招生调剂生
+2/96
-
【调剂信息】山东科技大学材料助剂研究团队招收调剂硕士研究生
+1/85
-
需要调剂化学专业的看过来
+1/40
-
喀什大学环境生态修复功能材料与技术团队接收2026年调剂研究生
+1/36
-
福建农林大学计算机科学与技术学硕招生
+1/35
-
汕头大研究生调剂招生
+1/31
-
江苏海洋大学+环境与化学工程学院+课题组招调剂生+第一批调剂
+2/22
-
★上海★上海工程技术大学·环境与资源创新中心（ICER）接收化工材料环境等学科调剂生
+1/8
-
【调剂上岸】985联合培养！1007/1055/08/07等，不限专业，想联培的速来！
+1/7
-
国家大人才课题组招收化学、材料化工类2026年调剂生
+1/5
-
中国科学院城市环境研究所与福建农林大学联合培养研究生调剂公告（第一批）
+1/5
-
吉林工程技术师范学院 材料与化工 （0856） 招收调剂
+1/5
-
福建师范大学环境微生物技术课题组接受2026级硕士调剂
+1/5
-
生物医学工程-生物医学信号处理方向博导求推荐
+1/3
-
0854,0858调剂招生
+1/3
-
找好工作来我这-广东唯一石化院校——资源与环境专硕招生
+1/2
-
太原科技大学材料科学与工程学院学硕、专硕调剂
+1/1
8楼2016-01-10 22:43:00
简单回复
jiantu2楼
2015-12-29 10:32
回复
linglingchen(金币+1): 谢谢参与
liangbk3楼
2015-12-29 11:05
回复
linglingchen(金币+1): 谢谢参与
tzynew4楼
2015-12-29 12:50
回复
linglingchen(金币+1): 谢谢参与
假大空5楼
2015-12-29 13:24
回复
linglingchen(金币+1): 谢谢参与
2015-12-29 13:42
回复
linglingchen(金币+1): 谢谢参与
好
2016-01-09 22:32
回复
1
